Novel thiazolidinedione derivatives with anti-obesity effects: Dual action as PTP1B inhibitors and PPAR-gamma activators
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bhattarai, Bharat Raj | - |
dc.contributor.author | Kafle, Bhooshan | - |
dc.contributor.author | Hwang, Ji-Sun | - |
dc.contributor.author | Ham, Seung Wook | - |
dc.contributor.author | Lee, Keun-Hyeung | - |
dc.contributor.author | Park, Hwangseo | - |
dc.contributor.author | Han, Inn-Oc | - |
dc.contributor.author | Cho, Hyeongjin | - |
dc.date.available | 2019-05-30T00:39:46Z | - |
dc.date.issued | 2010-11 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.issn | 1464-3405 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/22081 | - |
dc.description.abstract | Benzylidene-2,4-thiazolidinedione derivatives with substitutions at both the ortho and para-positions of the phenyl group were synthesized as PTP1B inhibitors with IC50 values in a low micromolar range. Compound 18l, the lowest, bore an IC50 of 1.3 mu M. In a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) promoter reporter gene assay, 18l was found to activate the transcription of the reporter gene with potencies comparable to those of troglitazone, rosiglitazone, and pioglitazone. In vivo efficacy of 18l as an anti-obesity and hypoglycemic agent was evaluated in a mouse model system. Compound 18l significantly suppressed weight gain and significantly improved blood parameters such as TG, total cholesterol and NEFA without overt toxic effects. (C) 2010 Elsevier Ltd. All rights reserved. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Novel thiazolidinedione derivatives with anti-obesity effects: Dual action as PTP1B inhibitors and PPAR-gamma activators | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2010.08.130 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.20, no.22, pp 6758 - 6763 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000283052900086 | - |
dc.identifier.scopusid | 2-s2.0-77958039797 | - |
dc.citation.endPage | 6763 | - |
dc.citation.number | 22 | - |
dc.citation.startPage | 6758 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 20 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Protein tyrosine phosphatase | - |
dc.subject.keywordAuthor | Thiazolidinedione | - |
dc.subject.keywordAuthor | PTP1B inhibitor | - |
dc.subject.keywordAuthor | PPAR-gamma activator | - |
dc.subject.keywordAuthor | Anti-obesity | - |
dc.subject.keywordPlus | TYROSINE-PHOSPHATASE 1B | - |
dc.subject.keywordPlus | INSULIN SENSITIVITY | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | 5-ARYLIDENE-2,4-THIAZOLIDINEDIONES | - |
dc.subject.keywordPlus | ADD-3878 | - |
dc.subject.keywordPlus | DOMAINS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | MICE | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.